{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T13:09:26Z","timestamp":1790600966820,"version":"4.1.0"},"reference-count":118,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive Toxicology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.reprotox.2021.10.010","type":"journal-article","created":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T18:10:57Z","timestamp":1634926257000},"page":"82-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Current knowledge, challenges, new perspectives of the study, and treatments of Autism Spectrum Disorder"],"prefix":"10.1016","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9334-4771","authenticated-orcid":false,"given":"Bruna","family":"Lotufo Denucci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7050-5560","authenticated-orcid":false,"given":"Larissa","family":"Silva de Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9558-4787","authenticated-orcid":false,"given":"Isabela","family":"Ferreira Lima Mota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Rocha Madureira Azevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Let\u00edcia","family":"Germino Veras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Victor","family":"Montenegro Luzardo Bicca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna","family":"de Miranda Santana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Beserra Pinheiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Gon\u00e7alves Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6849-6001","authenticated-orcid":false,"given":"M\u00e1rcia Renata","family":"Mortari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.reprotox.2021.10.010_bib0005","series-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-5\u00ae)","author":"American Psychiatric Association","year":"2013"},{"issue":"6","key":"10.1016\/j.reprotox.2021.10.010_bib0010","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1515\/revneuro-2014-0056","article-title":"Autism: cause factors, early diagnosis and therapies","volume":"25","author":"Bhat","year":"2014","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.reprotox.2021.10.010_bib0015","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3390\/brainsci10030163","article-title":"The neurochemistry of autism","volume":"10","author":"Marotta","year":"2020","journal-title":"Brain Science"},{"issue":"June (6)","key":"10.1016\/j.reprotox.2021.10.010_bib0020","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jaac.2017.03.013","article-title":"What is the male-to-female ratio in autism spectrum disorder? A systematic review and meta-analysis","volume":"56","author":"Loomes","year":"2017","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.reprotox.2021.10.010_bib0025","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.gde.2012.03.002","article-title":"Genetic architecture in autism spectrum disorder","volume":"22","author":"Devlin","year":"2012","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.reprotox.2021.10.010_bib0030","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.reprotox.2015.05.007","article-title":"Prenatal factors associated with autism spectrum disorder (ASD)","volume":"56","author":"Ornoy","year":"2015","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.reprotox.2021.10.010_bib0035","doi-asserted-by":"crossref","first-page":"26185","DOI":"10.1038\/srep26185","article-title":"Mean serum-level of common organic pollutants is predictive of behavioral severity in children with autism spectrum disorders","volume":"6","author":"Boggess","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.reprotox.2021.10.010_bib0040","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10519-006-9120-5","article-title":"Animal models relevant to schizophrenia and autism: validity and limitations","volume":"37","author":"Tordjman","year":"2007","journal-title":"Behav. Genet."},{"key":"10.1016\/j.reprotox.2021.10.010_bib0045","first-page":"1","article-title":"Neuropathology and animal models of autism: genetic and environmental factors","author":"Gadad","year":"2013","journal-title":"Autism Res. Treat."},{"key":"10.1016\/j.reprotox.2021.10.010_bib0050","series-title":"Epidemiology and Control of Neural Tube Defects","author":"Elwood","year":"1992"},{"key":"10.1016\/j.reprotox.2021.10.010_bib0055","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/stem.1820","article-title":"Wnt\/beta-catenin signaling regulates sequential fate decisions of murine cortical precursor cells","volume":"33","author":"Draganova","year":"2015","journal-title":"Stem Cells"},{"key":"10.1016\/j.reprotox.2021.10.010_bib0060","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1242\/dev.114173","article-title":"Ntf3 acts downstream of Sip1 in cortical postmitotic neurons to control progenitor cell fate through feedback signaling","volume":"141","author":"Parthasarathy","year":"2014","journal-title":"Development"},{"key":"10.1016\/j.reprotox.2021.10.010_bib0065","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.cell.2009.10.004","article-title":"Retinoic acid from the meninges regulates cortical neuron generation","volume":"139","author":"Siegenthaler","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.reprotox.2021.10.010_bib0070","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1126\/science.aad0314","article-title":"The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring","volume":"351","author":"Choi","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.reprotox.2021.10.010_bib0075","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.expneurol.2017.04.007","article-title":"Worms on the spectrum - C. elegans models in autism research","volume":"299","author":"Schmeisser","year":"2018","journal-title":"Exp. Neurol."},{"issue":"5","key":"10.1016\/j.reprotox.2021.10.010_bib0080","first-page":"379","article-title":"Genetic variant of glutathione peroxidase-1 in autism","volume":"73","author":"Ming","year":"2009","journal-title":"Brain Dev."},{"key":"10.1016\/j.reprotox.2021.10.010_bib0085","first-page":"356","article-title":"Risk of autistic disorder in affected offspring of mothers with a glutathione S-transferase P1 haplotyope","volume":"161","author":"Williams","year":"2007","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"10.1016\/j.reprotox.2021.10.010_bib0090","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.brainresbull.2014.10.006","article-title":"Altered behavioral development in Nrf2 knockout mice following early postnatal exposure to valproic acid","volume":"109","author":"Furnari","year":"2014","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.reprotox.2021.10.010_bib0095","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.bbr.2010.02.032","article-title":"Animal model of autism using GSTM1 knockout mice and early post-natal sodium valproate treatment","volume":"210","author":"Yochum","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.reprotox.2021.10.010_bib0100","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.neuron.2012.07.022","article-title":"Genetic removal of p70 S6 kinase 1 corrects molecular, synaptic, and behavioral phenotypes in fragile X syndrome mice","volume":"76","author":"Bhattacharya","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.reprotox.2021.10.010_bib0105","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/hmg\/dds406","article-title":"Female Mecp2(+\/-) mice display robust behavioral deficits on two different genetic backgrounds providing a framework for pre-clinical studies","volume":"22","author":"Samaco","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.reprotox.2021.10.010_bib0110","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.neuropharm.2013.04.038","article-title":"Prosocial effects of oxytocin in two mouse models of autism spectrum disorders","volume":"72","author":"Teng","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.reprotox.2021.10.010_bib0115","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neuropharm.2015.12.025","article-title":"Reversal of social deficits by subchronic oxytocin in two autism mouse models","volume":"105","author":"Teng","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.reprotox.2021.10.010_bib0120","doi-asserted-by":"crossref","first-page":"312","DOI":"10.5607\/en.2015.24.4.312","article-title":"Is oxytocin application for autism spectrum disorder evidence-based?","volume":"24","author":"Lee","year":"2015","journal-title":"Exp. Neurobiol."},{"key":"10.1016\/j.reprotox.2021.10.010_bib0125","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/978-3-319-52498-6_8","article-title":"The role of the oxytocin\/arginine vasopressin system in animal models of autism spectrum disorder","volume":"224","author":"Zhang","year":"2017","journal-title":"Adv. Anat. Embryol. Cell Biol."},{"key":"10.1016\/j.reprotox.2021.10.010_bib0130","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/7854_2017_15","article-title":"Oxytocin and animal models for autism spectrum disorder","volume":"35","author":"Wagner","year":"2018","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.reprotox.2021.10.010_bib0135","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.neubiorev.2016.12.037","article-title":"The BTBR mouse model of idiopathic autism\u2014Current view on mechanisms","volume":"76","author":"Meyza","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.reprotox.2021.10.010_bib0140","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.brainres.2008.01.055","article-title":"VPA-induced apoptosis and behavioral deficits in neonatal mice","volume":"1203","author":"Yochum","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.reprotox.2021.10.010_bib0145","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.neuroscience.2020.02.029","article-title":"Long-lasting behavioral and neuroanatomical effects of postnatal valproic acid treatment","volume":"434","author":"Norton","year":"2020","journal-title":"Neuroscience"},{"key":"10.1016\/j.reprotox.2021.10.010_bib0150","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.bbr.2008.12.016","article-title":"Immune involvement in schizophrenia and autism: etiology, pathology and animal models","volume":"204","author":"Patterson","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.reprotox.2021.10.010_bib0155","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1016\/j.ajpath.2011.02.042","article-title":"Placental TNF-alpha signaling in illness-induced complications of pregnancy","volume":"178","author":"Carpentier","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.reprotox.2021.10.010_bib0160","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.braindev.2014.03.007","article-title":"Maternal viral infection during pregnancy impairs development of fetal serotonergic neurons","volume":"37","author":"Ohkawara","year":"2015","journal-title":"Brain Dev."},{"key":"10.1016\/j.reprotox.2021.10.010_bib0165","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.bbr.2006.06.013","article-title":"Abnormal social behaviors in young and adult rats neonatally infected with Borna disease virus","volume":"176","author":"Lancaster","year":"2007","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.reprotox.2021.10.010_bib0170","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/sj.npp.1300518","article-title":"Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism","volume":"30","author":"Schneider","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.reprotox.2021.10.010_bib0175","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.psyneuen.2008.02.011","article-title":"Gender-specific behavioral and immunological alterations in an animal model of autism induced by prenatal exposure to valproic acid","volume":"33","author":"Schneider","year":"2008","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.reprotox.2021.10.010_bib0180","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/sj.npp.1301453","article-title":"Abnormal fear conditioning and amygdala processing in an animal model of autism","volume":"33","author":"Markram","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.reprotox.2021.10.010_bib0185","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0890-6238(97)80001-U","article-title":"Linking etiologies in humans and animal models: studies of autism","volume":"11","author":"Rodier","year":"1997","journal-title":"Reprod. Toxicol. (Elmsford, N.Y.)"},{"key":"10.1016\/j.reprotox.2021.10.010_bib0190","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ntt.2013.01.004","article-title":"In utero exposure to valproic acid and autism\u2014A current review of clinical and animal studies","volume":"36","author":"Roullet","year":"2013","journal-title":"Neurotoxicol. Teratol."},{"issue":"33","key":"10.1016\/j.reprotox.2021.10.010_bib0195","first-page":"438","article-title":"Valproate: a new cause of birth defects \u2013 report from Italy and follow-up from France","volume":"32","author":"Centers for Disease Control and Prevention (CDC)","year":"1983","journal-title":"Morbidity Mortality Weekly Rep."},{"issue":"8304","key":"10.1016\/j.reprotox.2021.10.010_bib0200","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(82)90908-4","article-title":"Maternal valproic acid and congenital neural tube defects","volume":"2","author":"Robert","year":"1982","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.reprotox.2021.10.010_bib0205","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1056\/NEJM199103073241006","article-title":"Spina bifida in infants of women treated with carbamazepine during pregnancy","volume":"324","author":"Rosa","year":"1991","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.reprotox.2021.10.010_bib0210","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/WCO.0000000000000659","article-title":"Teratogenicity of antiepileptic drugs","volume":"32","author":"Tomson","year":"2019","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.reprotox.2021.10.010_bib0215","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.3390\/ijms20051074","article-title":"Prevention or amelioration of autism-like symptoms in animal models: will it bring us closer to treating human ASD?","volume":"20","author":"Ornoy","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.reprotox.2021.10.010_bib0220","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/ajmg.1320190308","article-title":"The fetal valproate syndrome","volume":"19","author":"DiLiberti","year":"1984","journal-title":"Am. J. Med. Genet."},{"issue":"4","key":"10.1016\/j.reprotox.2021.10.010_bib0225","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1469-8749.1994.tb11858.x","article-title":"Fetal valproate syndrome: clinical and neuro-developmental features in two sibling pairs","volume":"36","author":"Christianson","year":"1994","journal-title":"Dev. Med. Child Neurol."},{"issue":"23","key":"10.1016\/j.reprotox.2021.10.010_bib0230","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1212\/01.wnl.0000339399.64213.1a","article-title":"Autism spectrum disorders following in utero exposure to antiepileptic drugs","volume":"71","author":"Bromley","year":"2008","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.reprotox.2021.10.010_bib0235","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1017\/S0012162205001076","article-title":"Characteristics of fetal anticonvulsant syndrome associated autistic disorder","volume":"47","author":"Rasalam","year":"2005","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.reprotox.2021.10.010_bib0240","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-3-319-52498-6_2","article-title":"Neuroanatomy and neuropathology of autism spectrum disorder in humans","volume":"224","author":"Ecker","year":"2017","journal-title":"Adv. Anat. Embryol. Cell Biol."},{"issue":"1","key":"10.1016\/j.reprotox.2021.10.010_bib0245","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1017\/S1461145711001714","article-title":"Autism-like behaviours with transient histone hyperacetylation in mice treated prenatally with valproic acid","volume":"16","author":"Kataoka","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.reprotox.2021.10.010_bib0250","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.expneurol.2017.04.017","article-title":"The valproic acid-induced rodent model of autism","volume":"299","author":"Nicolini","year":"2018","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.reprotox.2021.10.010_bib0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.reprotox.2009.02.014","article-title":"Valproic acid in pregnancy: how much are we endangering the embryo and fetus?","volume":"28","author":"Ornoy","year":"2009","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.reprotox.2021.10.010_bib0260","doi-asserted-by":"crossref","first-page":"285","DOI":"10.5607\/en.2015.24.4.285","article-title":"Exploring the validity of valproic acid animal model of autism","volume":"24","author":"Mabunga","year":"2015","journal-title":"Exp. Neurobiol."},{"key":"10.1016\/j.reprotox.2021.10.010_bib0265","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s12035-013-8535-2","article-title":"Pax6-dependent cortical glutamatergic neuronal differentiation regulates autism-like behavior in prenatally valproic acid-exposed rat offspring","volume":"49","author":"Kim","year":"2014","journal-title":"Mol. Neurobiol."},{"issue":"6","key":"10.1016\/j.reprotox.2021.10.010_bib0270","doi-asserted-by":"crossref","DOI":"10.1023\/A:1013238809666","article-title":"Density and distribution of hippocampal neurotransmitter receptors in autism: an autoradiographic study","volume":"31","author":"Blatt","year":"2001","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.reprotox.2021.10.010_bib0275","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ijdevneu.2004.05.004","article-title":"Maternal administration of thalidomide or valproic acid causes abnormal serotonergic neurons in the offspring: implication for pathogenesis of autism","volume":"23","author":"Miyazaki","year":"2005","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.reprotox.2021.10.010_bib0280","first-page":"576","article-title":"Increased monoamine concentration in the brain and blood of fetal thalidomide- and valproic acid\u2013exposed rat: putative animal models for autism","volume":"52","author":"Narita","year":"2002","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.reprotox.2021.10.010_bib0285","doi-asserted-by":"crossref","first-page":"36734","DOI":"10.1074\/jbc.M101287200","article-title":"Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen","volume":"276","author":"Phiel","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.reprotox.2021.10.010_bib0290","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.expneurol.2017.11.004","article-title":"Animal models in autism research: the legacy of Paul H. Patterson","volume":"299","author":"Pardo","year":"2018","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.reprotox.2021.10.010_bib0295","first-page":"469","article-title":"Beta-carotene as a novel therapy for the treatment of \u201cAutistic like behavior\u201d in animal models of Autism","volume":"304","author":"Avraham","year":"2017","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.reprotox.2021.10.010_bib0300","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1126\/scitranslmed.3003501","article-title":"Negative allosteric modulation of the mGluR5 receptor reduces repetitive behaviors and rescues social deficits in mouse models of autism","volume":"4","author":"Silverman","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.reprotox.2021.10.010_bib0305","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1523\/JNEUROSCI.2010-17.2017","article-title":"Insulin-like growth factor II targets the mTOR pathway to reverse autism-like phenotypes in mice","volume":"38","author":"Steinmetz","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/j.reprotox.2021.10.010_bib0310","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.neulet.2006.08.017","article-title":"High frequency of neurexin 1beta signal peptide structural variants in patients with autism","volume":"409","author":"Feng","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.reprotox.2021.10.010_bib0315","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nature07953","article-title":"Autism genome-wide copy number variation reveals ubiquitin and neuronal genes","volume":"459","author":"Glessner","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.reprotox.2021.10.010_bib0320","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/nature07456","article-title":"Neuroligins and neurexins link synaptic function to cognitive disease","volume":"455","author":"Sudhof","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.reprotox.2021.10.010_bib0325","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.neulet.2008.04.074","article-title":"Neurexin 1alpha structural variants associated with autism","volume":"438","author":"Yan","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.reprotox.2021.10.010_bib0330","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039277","article-title":"Functional phenotypic rescue of Caenorhabditis elegans neuroligin-deficient mutants by the human and rat NLGN1 genes","volume":"7","author":"Calahorro","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.reprotox.2021.10.010_bib0335","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jpain.2015.02.001","article-title":"Decreased sensitivity to thermal stimuli in adolescents with autism spectrum disorder: relation to symptomatology and cognitive ability","volume":"16","author":"Duerden","year":"2015","journal-title":"J. Pain"},{"key":"10.1016\/j.reprotox.2021.10.010_bib0340","doi-asserted-by":"crossref","first-page":"4061","DOI":"10.1073\/pnas.72.10.4061","article-title":"Normal and mutant thermotaxis in the nematode Caenorhabditis elegans","volume":"72","author":"Hedgecock","year":"1975","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.reprotox.2021.10.010_bib0345","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10048-013-0377-6","article-title":"Neuroligin modulates the locomotory dopaminergic and serotonergic neuronal pathways of C. elegans","volume":"14","author":"Izquierdo","year":"2013","journal-title":"Neurogenetics"},{"issue":"5","key":"10.1016\/j.reprotox.2021.10.010_bib0350","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0243121","article-title":"Investigating autism associated genes in C. elegans reveals candidates with a role in social behaviour","volume":"16","author":"Rawsthorne","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.reprotox.2021.10.010_bib0355","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.expneurol.2017.02.004","article-title":"Zebrafish models of autism spectrum disorder","volume":"299","author":"Meshalkina","year":"2017","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.reprotox.2021.10.010_bib0360","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1093\/hmg\/ddv138","article-title":"Two knockdown models of the autism genes SYNGAP1 and SHANK3 in zebrafish produce similar behavioral phenotypes associated with embryonic disruptions of brain morphogenesis","volume":"24","author":"Kozol","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.reprotox.2021.10.010_bib0365","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1176\/appi.ajp.2020.20010015","article-title":"A genetics-first approach to dissecting the heterogeneity of autism: phenotypic comparison of autism risk copy number variants","volume":"178","author":"Chawner","year":"2021","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.reprotox.2021.10.010_bib0370","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nrn2851","article-title":"Behavioural phenotyping assays for mouse models of autism","volume":"11","author":"Silverman","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.reprotox.2021.10.010_bib0375","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.expneurol.2017.07.021","article-title":"Advances in nonhuman primate models of autism: integrating neuroscience and behavior","volume":"299","author":"Bauman","year":"2018","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.reprotox.2021.10.010_bib0380","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1371\/journal.pone.0104433","article-title":"Gender-dependent effects of maternal immune activation on the behavior of mouse offspring","volume":"9","author":"Xuan","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.reprotox.2021.10.010_bib0385","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s40265-013-0021-7","article-title":"Pharmacotherapy for the core symptoms in autistic disorder: current status of the research","volume":"73","author":"Farmer","year":"2013","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.reprotox.2021.10.010_bib0390","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s12264-017-0100-y","article-title":"An overview of autism spectrum disorder, heterogeneity and treatment options","volume":"33","author":"Masi","year":"2017","journal-title":"Neurosci. Bull."},{"issue":"1","key":"10.1016\/j.reprotox.2021.10.010_bib0395","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13229-020-00372-z","article-title":"Placebo response in pharmacological and dietary supplement trials of autism spectrum disorder (ASD): systematic review and meta-regression analysis","volume":"11","author":"Siafis","year":"2020","journal-title":"Mol. Autism"},{"issue":"4","key":"10.1016\/j.reprotox.2021.10.010_bib0400","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s40272-016-0183-3","article-title":"Head-to-head comparison of aripiprazole and risperidone in the treatment of ADHD symptoms in children with autistic spectrum disorder and ADHD: a pilot, open-label, randomized controlled study","volume":"18","author":"Lamberti","year":"2016","journal-title":"Pediatr. Drugs"},{"key":"10.1016\/j.reprotox.2021.10.010_bib0405","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/136158","article-title":"Adverse effects of risperidone in children with autism spectrum disorders in a naturalistic clinical setting at Siriraj Hospital, Thailand","volume":"2014","author":"Boon-Yasidhi","year":"2014","journal-title":"Psychiatry J."},{"issue":"11","key":"10.1016\/j.reprotox.2021.10.010_bib0410","first-page":"779","volume":"16","author":"Mcgavin","year":"2002","journal-title":"Aripiprazole"},{"issue":"8","key":"10.1016\/j.reprotox.2021.10.010_bib0415","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1089\/cap.2012.0075","article-title":"Aripiprazole treatment of irritability associated with autistic disorder and the relationship between prior antipsychotic exposure, adverse events, and weight change","volume":"23","author":"Mankoski","year":"2013","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.reprotox.2021.10.010_bib0420","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1007\/s00213-017-4703-9","article-title":"Risperidone and aripiprazole alleviate prenatal valproic acid-induced abnormalities in behaviors and dendritic spine density in mice","volume":"234","author":"Hara","year":"2017","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.reprotox.2021.10.010_bib0425","doi-asserted-by":"crossref","first-page":"203","DOI":"10.15547\/tjs.2019.03.002","article-title":"Effects of risperidone on learning and memory parameters in experimental model of autism","volume":"17","author":"Varadinova","year":"2019","journal-title":"Trakia J. Sci."},{"key":"10.1016\/j.reprotox.2021.10.010_bib0430","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.bbr.2015.04.022","article-title":"Reduced prefrontal dopaminergic activity in valproic acid-treated mouse autism model","volume":"289","author":"Hara","year":"2015","journal-title":"Behav. Brain Res."},{"issue":"April (3)","key":"10.1016\/j.reprotox.2021.10.010_bib0435","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3109\/15622975.2015.1085597","article-title":"Excitatory\/inhibitory imbalance in autism spectrum disorders: implications for interventions and therapeutics","volume":"17","author":"Uzunova","year":"2016","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.reprotox.2021.10.010_bib0440","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.neuropharm.2016.09.014","article-title":"Agmatine rescues autistic behaviors in the valproic acid-induced animal model of autism","volume":"113","author":"Kim","year":"2017","journal-title":"Neuropharmacology"},{"issue":"November","key":"10.1016\/j.reprotox.2021.10.010_bib0445","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.neuroscience.2015.11.010","article-title":"The serotonin system in autism spectrum disorder: from biomarker to animal models","volume":"321","author":"Muller","year":"2016","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.reprotox.2021.10.010_bib0450","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13229-018-0243-3","article-title":"Brain hyperserotonemia causes autism-relevant social deficits in mice","volume":"9","author":"Tanaka","year":"2018","journal-title":"Mol. Autism"},{"key":"10.1016\/j.reprotox.2021.10.010_bib0455","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s10803-006-0117-y","article-title":"A new neurobehavioral model of autism in mice: pre- and post-natal exposure to sodium valproate","volume":"36","author":"Veenstra-VanderWeele","year":"2006","journal-title":"J. Autism Dev. Disorders"},{"issue":"9","key":"10.1016\/j.reprotox.2021.10.010_bib0460","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/tp.2016.182","article-title":"Targeting anandamide metabolism rescues core and associated autistic-like symptoms in rats prenatally exposed to valproic acid","volume":"6","author":"Servadio","year":"2016","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.reprotox.2021.10.010_bib0465","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1089\/can.2015.0008","article-title":"Enhancement of anandamide-mediated endocannabinoid signaling corrects autism-related social impairment","volume":"1","author":"Wei","year":"2016","journal-title":"Cannabis Cannabinoid Res."},{"issue":"August","key":"10.1016\/j.reprotox.2021.10.010_bib0470","first-page":"1","article-title":"Cannabidivarin treatment ameliorates autism-like behaviors and restores hippocampal endocannabinoid system and glia alterations induced by prenatal valproic acid exposure in rats","volume":"13","author":"Zamberletti","year":"2019","journal-title":"Front. Cell. Neurosci."},{"issue":"10","key":"10.1016\/j.reprotox.2021.10.010_bib0475","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s40262-013-0079-0","article-title":"Pharmacokinetics and pharmacokinetic-pharmacodynamic correlations of therapeutic peptides","volume":"52","author":"Diao","year":"2013","journal-title":"Clin. Pharmacokinet."},{"issue":"5","key":"10.1016\/j.reprotox.2021.10.010_bib0480","first-page":"6","article-title":"Venom peptides as human pharmaceuticals","volume":"4","author":"Miljanich","year":"1997","journal-title":"Sci. Med."},{"issue":"11","key":"10.1016\/j.reprotox.2021.10.010_bib0485","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/psc.701","article-title":"Small peptides, big world: biotechnological potential in neglected bioactive peptides from arthropod venoms","volume":"11","author":"Pimenta","year":"2005","journal-title":"J. Pept. Sci."},{"key":"10.1016\/j.reprotox.2021.10.010_bib0490","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2004.03.049","article-title":"Spider and wasp neurotoxins: pharmacological and biochemical aspects","volume":"493","author":"Beleboni","year":"2004","journal-title":"Eur. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.reprotox.2021.10.010_bib0495","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1016\/j.drudis.2019.09.004","article-title":"Animal venoms: therapeutic tools for tackling Parkinson\u2019s disease","volume":"24","author":"Amaral","year":"2019","journal-title":"Drug Discov. Today"},{"issue":"11","key":"10.1016\/j.reprotox.2021.10.010_bib0500","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1517\/14712598.2011.621940","article-title":"Venoms as a platform for human drugs: translating toxins into therapeutics","volume":"11","author":"King","year":"2011","journal-title":"Expert Opin. Biol. Ther."},{"issue":"15","key":"10.1016\/j.reprotox.2021.10.010_bib0505","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.4155\/fmc.14.102","article-title":"The future of venoms-based drug discovery: an interview with Glenn King","volume":"6","author":"King","year":"2014","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.reprotox.2021.10.010_bib0510","first-page":"21","article-title":"Neuroactive compounds obtained from arthropod venoms as new therapeutic platforms for the treatment of neurological disorders","volume":"2015","author":"Monge-Fuentes","year":"2015","journal-title":"J. Venom. Anim. Toxins Incl. Trop. Dis."},{"issue":"9","key":"10.1016\/j.reprotox.2021.10.010_bib0515","doi-asserted-by":"crossref","first-page":"550","DOI":"10.3390\/toxins12090550","article-title":"Fraternine, a novel wasp peptide, protects against motor impairments in 6-OHDA model of Parkinsonism","volume":"12","author":"Biolchi","year":"2020","journal-title":"Toxins"},{"key":"10.1016\/j.reprotox.2021.10.010_bib0520","article-title":"Neuropolybin: a new antiseizure peptide obtained from wasp venom","volume":"181","author":"Silva","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.reprotox.2021.10.010_bib0525","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.lfs.2016.02.063","article-title":"Anxiolytic activity and evaluation of potentially adverse effects of a bradykinin-related peptide isolated from a social wasp venom","volume":"149","author":"dos Anjos","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.reprotox.2021.10.010_bib0530","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.toxicon.2016.09.015","article-title":"Anxiolytic-like effect of a novel peptide isolated from the venom of the social wasp Synoeca surinama","volume":"122","author":"Gomes","year":"2016","journal-title":"Toxicon"},{"issue":"2","key":"10.1016\/j.reprotox.2021.10.010_bib0535","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/(SICI)1099-0461(2000)14:2<88::AID-JBT4>3.0.CO;2-G","article-title":"Effects of the crude venom of the social wasp Agelaia vicina on gamma-aminobutyric acid and glutamate uptake in synaptosomes from rat cerebral cortex","volume":"14","author":"Pizzo","year":"2000","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"1","key":"10.1016\/j.reprotox.2021.10.010_bib0540","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.brainres.2004.10.027","article-title":"Effects of microinjections of neurotoxin AvTx8, isolated from the social wasp Agelaia vicina (Hymenoptera, Vespidae) venom, on GABAergic nigrotectal pathways","volume":"1031","author":"de Oliveira","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.reprotox.2021.10.010_bib0545","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.21941","article-title":"Isolation and chemical characterization of agelaiatoxin8 (AvTx8) from Agelaia vicina wasp venom and its biological effects on GABA neurotransmission","volume":"31","author":"Pizzo","year":"2017","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.reprotox.2021.10.010_bib0550","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3389\/fncel.2018.00355","article-title":"Neonatal oxytocin treatment ameliorates autistic-like behaviors and oxytocin deficiency in valproic acid-induced rat model of autism","volume":"12","author":"Dai","year":"2018","journal-title":"Front. Cell. Neurosci."},{"issue":"July","key":"10.1016\/j.reprotox.2021.10.010_bib0555","first-page":"262","article-title":"Oxytocin improves animal behaviors and ameliorates oxidative stress and inflammation in autistic mice","volume":"107","author":"Wang","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.reprotox.2021.10.010_bib0560","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1021\/acs.molpharmaceut.7b00991","article-title":"Delivery of oxytocin to the brain for the treatment of autism spectrum disorder by nasal application","volume":"15","author":"Tanaka","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.reprotox.2021.10.010_bib0565","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41398-020-01069-w","article-title":"Oxytocin treatment attenuates amygdala activity in autism: a treatment-mechanism study with long-term follow-up","volume":"10","author":"Bernaerts","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.reprotox.2021.10.010_bib0570","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.bbi.2010.03.005","article-title":"Effects of prenatal infection on brain development and behavior: A review of findings from animal models","volume":"24","author":"Boksa","year":"2010","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.reprotox.2021.10.010_bib0575","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s10803-006-0117-y","article-title":"A new neurobehavioral model of autism in mice: pre- and post-natal exposure to sodium valproate","volume":"36","author":"Wagner","year":"2006","journal-title":"J. Autism Develop. Disorders"},{"issue":"Pt A","key":"10.1016\/j.reprotox.2021.10.010_bib0580","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.nbd.2015.08.003","article-title":"Neuronal migration disorders: Focus on the cytoskeleton and epilepsy","volume":"92","author":"Stouffer","year":"2016","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.reprotox.2021.10.010_bib0585","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0920-1211(96)00039-3","article-title":"Neuronal migration disorders and epilepsy: a morphological analysis of three surgically treated patients","volume":"26","author":"Battaglia","year":"1996","journal-title":"Epilepsy Res."},{"issue":"8","key":"10.1016\/j.reprotox.2021.10.010_bib0590","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1001\/jamapediatrics.2014.210","article-title":"Costs of autism spectrum disorders in the United Kingdom and the United States","volume":"168","author":"Buescher","year":"2014","journal-title":"JAMA Pediatr."}],"container-title":["Reproductive Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623821001660?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623821001660?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:56:59Z","timestamp":1760191019000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890623821001660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":118,"alternative-id":["S0890623821001660"],"URL":"https:\/\/doi.org\/10.1016\/j.reprotox.2021.10.010","relation":{},"ISSN":["0890-6238"],"issn-type":[{"value":"0890-6238","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current knowledge, challenges, new perspectives of the study, and treatments of Autism Spectrum Disorder","name":"articletitle","label":"Article Title"},{"value":"Reproductive Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reprotox.2021.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}